Accelerated schedule of hepatitis B vaccination in high‐risk youth

Publisher Website
Google Scholar
Abstract
To perform a feasibility and immunogenicity study of an accelerated schedule of hepatitis B immunization for high-risk youth. High-risk adolescents attending a youth health centre and nearby youth refuges were immunized with Engerix-B recombinant vaccine, 20 micrograms intramuscularly, at 0, 2 and 6 weeks. Serology was performed prior to immunization and 3 months after the third dose. Forty-two subjects (27 female) aged 13-20 years entered the study. Two (4.8%), already hepatitis B virus (HBV) seropositive, were excluded. Thirty-six of 40 subjects had one or more risk factors for HBV. Participants were often elusive, needing multiple attempts to establish contact. Twenty (50%) of the 40 completed three immunizations and all 14 studied developed anti-hepatitis B surface titres of > 100 mlU/mL (geometric mean titre 630 mlU/mL, 95% confidence intervals 309-1290). High-risk youth can be immunized against hepatitis B successfully using an accelerated schedule, but compliance is difficult.